The hemp industry continues to be a top investment target for well-capitalized Canadian cannabis companies.
But that doesn’t mean they’re all looking to grow the plant.
Organigram CEO Greg Engel, whose New Brunswick-based company began trading this week on the Nasdaq, says CBD offers a big opportunity to enter U.S. markets. However, he added his company doesn’t plan to start growing hemp.
“We don’t want to be a cultivator,” he told financial-news television network Cheddar. “There is lots of hemp cultivation happening.”
Other Canadian investments in U.S. hemp this week included:
- The closing of a $30 million deal for Sol Global of Toronto to buy a majority stake in Tennessee hemp grower and CBD manufacturer Bluhen Botanicals.
- A Vancouver cannabis real-estate firm that owns several Washington state marijuana companies, Bougainville Ventures, acquiring Oregon hemp grower Worm Castings Farm for $350,000 and some stock.
The hemp-derived CBD market offers a legal path to U.S. cannabis consumers for Canadian companies looking to establish a toehold here.
Subscribe to our Newsletter
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers